ProCE Banner Activity

Contemporary Approaches to Treating Polycythemia Vera: A Conversation Between Experts

Podcast Episodes

Listen as experts discuss how they tailor current therapeutic options for different patients with polycythemia vera.

Released: January 11, 2023

Expiration: January 10, 2024

No longer available for credit.

Share

Faculty

Raajit K. Rampal

Raajit K. Rampal, MD, PhD

Associate Member
Director
MPN and Rare Hematologic Malignancies Program
Director
Center for Hematologic Malignancies
Memorial Sloan Kettering Cancer Center
New York, New York

Brady L. Stein

Brady L. Stein, MD, MHS

Professor of Medicine
Department of Hematology/Oncology
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

GSK

Incyte Corporation

PharmaEssentia Corp

Faculty Disclosure

Primary Author

Raajit K. Rampal, MD, PhD

Associate Member
Director
MPN and Rare Hematologic Malignancies Program
Director
Center for Hematologic Malignancies
Memorial Sloan Kettering Cancer Center
New York, New York

Raajit Rampal, MD, PhD: consultant: AbbVie, Blueprint, Celgene/Bristol-Myers Squibb, Constellation/MorphoSys, CTI, Galecto, Incyte, Karyopharm, PharmaEssentia, Servier, Sierra Oncology/GlaxoSmithKline, Sumitomo Dainippon Kartos, Zentails; researcher: Constellation Pharmaceuticals, Ryvu, Stemline Therapeutics, Zentalis.

Brady L. Stein, MD, MHS

Professor of Medicine
Department of Hematology/Oncology
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Brady Stein, MD, MHS: consultant/advisor/speaker: PharmaEssentia